NASDAQ:BCDA

Biocardia Stock Insider Trading

etoro logo Buy BCDA
*Your capital is at risk
$0.91
-0.0046 (-0.503%)
At Close: Jul 13, 2026

BioCardia Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.01. In total, the insiders bought 4.65M and sold 95K BCDA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.01
Buy 4.65M shares
Sell 95K shares
97% Buy Activity
Moderate Negative Correlation
Sell Signal Low Confidence
Jul 02, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 99.01.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 10, 2026
Buy
Common Stock
P-Purchase
Altman Peter
President And CEO
CEO / President 1 000
Value: $940
Jul 09, 2026
Buy
Common Stock
P-Purchase
Altman Peter
President And CEO
CEO / President 1 000
Value: $900
Jul 08, 2026
Buy
Common Stock
P-Purchase
Altman Peter
President And CEO
CEO / President 5 500
Value: $5K
Jul 08, 2026
Buy
Common Stock
P-Purchase
Altman Peter
President And CEO
CEO / President 5 400
Value: $5K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Facteau Bill
Director
Director 8 000
Value: $10K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Moyes Jay M
Director
Director 8 000
Value: $10K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Allen Jim L.
Director
Director 8 000
Value: $10K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Blank Andrew Scott
Director
Director 8 000
Value: $10K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Gillis Edward M
Senior Vice President, Devices
CEO / President 29 442
Value: $35.3K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Mcclung David
Chief Financial Officer
C-Suite Officer 41 501
Value: $49.8K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Altman Peter
President And CEO
CEO / President 57 688
Value: $69.2K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Stertzer Simon H
Director
Director 8 000
Value: $10K
Jul 06, 2026
Buy
Stock Option (right to buy)
A-Award
Slosman Marvin
Director
Director 8 000
Value: $10K
Jul 02, 2026
Sell
Common Stock
F-InKind
Gillis Edward M
Senior Vice President, Devices
CEO / President 17 269
Value: $21.4K
Jul 02, 2026
Sell
Common Stock
F-InKind
Mcclung David
Chief Financial Officer
C-Suite Officer 23 125
Value: $28.7K
Jul 02, 2026
Sell
Common Stock
F-InKind
Altman Peter
President And CEO
CEO / President 54 606
Value: $67.7K
Jun 29, 2026
Buy
Common Stock
A-Award
Altman Peter
President And CEO
CEO / President 110 625
Value: $132.8K
Jun 29, 2026
Buy
Common Stock
A-Award
Mcclung David
Chief Financial Officer
C-Suite Officer 60 483
Value: $72.6K
Jun 29, 2026
Buy
Common Stock
A-Award
Gillis Edward M
Senior Vice President, Devices
CEO / President 39 521
Value: $47.4K
Jun 23, 2026
Buy
Common Stock
P-Purchase
Stertzer Simon H
Director
Director 39 000
Value: $39.0K
Jun 22, 2026
Buy
Common Stock
P-Purchase
Stertzer Simon H
Director
Director 70 200
Value: $64.6K
Jun 18, 2026
Buy
Common Stock
P-Purchase
Altman Peter
President And CEO
CEO / President 800
Value: $768
Jun 17, 2026
Buy
Common Stock
P-Purchase
Altman Peter
President And CEO
CEO / President 1 500
Value: $1K
Jun 09, 2026
Buy
Common Stock
P-Purchase
Altman Peter
President And CEO
CEO / President 5 000
Value: $4K
May 20, 2026
Buy
Common Stock
P-Purchase
Altman Peter
President And CEO
CEO / President 1 500
Value: $1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BIOCARDIA, INC.
BioCardia
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE